Literature DB >> 21063531

Successful treatment of molluscum contagiosum with a zinc oxide cream containing colloidal oatmeal extracts.

Gilles Safa1, Laure Darrieux.   

Abstract

Entities:  

Year:  2010        PMID: 21063531      PMCID: PMC2965925          DOI: 10.4103/0019-5154.70679

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, Molluscum contagiosum (MC) is among the most common viral skin infections seen in children. Although the lesions may resolve spontaneously over a period of a few months or years, there are several reasons to treat them: i) the lesions can be cosmetically unappealing, ii) patients may develop a pruritic eczematous eruption, and iii) the lesions can be numerous and recurrent, especially in patients with atopic dermatitis. No therapy is universally effective. We report herein six cases of children having MC who were treated with a zinc oxide cream containing colloidal oatmeal extracts (Avena rhealba) with dramatic results. Six healthy children with ≥ 10 cutaneous lesions of MC were treated in this open study. No other therapeutic procedures were undertaken with this treatment. Parents were instructed to apply the cream once daily at bed time to all the lesions for four weeks and the patients were evaluated at baseline and after four weeks. The children were 5-11 years old (mean age: 8.1 years) and 2/6 children (33%) had a history of atopic dermatitis. At the end of the four week treatment period, 4/6 children (66%) had complete resolution of their lesions [Figures 1a and 1b] and the remainder (2 out of 6) had partial response (≥ 50% decrease in the total number of MC lesions)
Figure 1a

Photographs of MC before treatment

Figure 1b

Photographs of MC after a four week treatment with a zinc oxide cream containing colloidal oatmeal extracts

Photographs of MC before treatment Photographs of MC after a four week treatment with a zinc oxide cream containing colloidal oatmeal extracts MC is caused by MC virus, a DNA virus of the poxvirus family that replicates only in human epidermal keratinocytes.[1] A variety of therapies exist for the treatment of MC, and all have their own drawbacks, thus warranting the need for a non-destructive, self-administered topical therapy that is both safe and efficacious. Taking this into consideration, we have undertaken an open trial with a zinc oxide cream containing colloidal oatmeal extracts. Colloidal oatmeal is present in a variety of dermatological and antiirritant products and has antiinflammatory properties. Recently, a study demonstrated inhibitory effects of oat extract on eicosanoid formation, expression of cytosolic phospholipase A2 (PLA2), and arachidonic acid mobilization in human keratinocytes.[2] We hypothesize that these antiinflammatory properties may play a role in the dramatic antiviral response observed in the six children in this study. Indeed, PLA2 activity was found to be critical for infectivity of some viruses such as parvoviruses.[3] In addition, studies suggested that poxviruses have an obligate requirement for arachidonic acid metabolites during replication and possess multiple genes that regulate arachidonate metabolism.[4] Obviously, randomized controlled studies are needed to confirm the effectiveness of this treatment, but its excellent safety profile appears to offer an attractive therapeutic option. In conclusion, our findings may provide a promising new therapeutic approach to the treatment of MC and are also in agreement with recent evidence in the literature which suggests the need for therapeutic options other than curettage in patients with numerous lesions.[5]
  5 in total

1.  Curettage treatment for molluscum contagiosum: a follow-up survey study.

Authors:  T Simonart; V De Maertelaer
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

Review 2.  Molluscum contagiosum.

Authors:  S L Gottlieb; P L Myskowski
Journal:  Int J Dermatol       Date:  1994-07       Impact factor: 2.736

3.  Avena Rhealba inhibits A23187-stimulated arachidonic acid mobilization, eicosanoid release, and cPLA2 expression in human keratinocytes: potential in cutaneous inflammatory disorders.

Authors:  Marie-Françoise Aries; Clémence Vaissiere; Eric Pinelli; Bernard Pipy; Marie Charveron
Journal:  Biol Pharm Bull       Date:  2005-04       Impact factor: 2.233

4.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

5.  Poxvirus-induced alteration of arachidonate metabolism.

Authors:  G J Palumbo; W C Glasgow; R M Buller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.